While blockade of IL-6 by adding neutralizing antibodies against IL-6 and the IL-6 receptor α-chain at the beginning of the coculture greatly reduced the inhibitory effect of TLR7 Epacadostat solubility dmso ligand on TGF-β-induced Foxp3 expression (13.9±0.3 versus 52.1±3.3% inhibition, p<0.01), neutralizing antibodies against IL-4 (31.3±8.8 versus 52.1±3.3% inhibition, p=0.04) and against IFN-γ (32.5±13.9 versus 52.1±3.3% inhibition, p=0.13) had only minor effects. However, simultaneous blockade of IL-6, IFN-γ,

and IL-4 from the beginning of the coculture entirely abrogated the inhibitory effect of TLR7 ligand on Foxp3 expression after 4 days (2.4±2.3 versus 52.1±3.3% inhibition, p<0.01, Fig. 3D). Neutralization of IL-6 in the supernatant of DCs stimulated with TLR7 ligand also reduced its inhibitory effect on TGF-β-induced Foxp3 expression in TLR7−/− T cells stimulated with anti-CD3/anti-CD28 (Supporting Information Fig. S1C). Accordingly, addition of recombinant IL-6 at the beginning of the DC–T-cell coculture significantly reduced Foxp3 expression

on day 4 (Fig. 3E). Thus, mostly IL-6 and to a minor extent IFN-γ and IL-4 produced in the DC–T-cell coculture are responsible for the observed reduction in Foxp3 expression in the presence of TLR7 ligand. The reduced percentage of Foxp3-expressing T cells measured after 4 days of DC–T-cell APO866 cost coculture in the presence of TLR7 ligand could be due to reduced initial induction of Foxp3 expression by TGF-β in naïve T cells or to downregulation of Foxp3 expression during the coculture. Alternatively, reduced proliferation or survival of induced Foxp3+ as compared with Foxp3− T cells in the coculture could be responsible for the observed effect of TLR7 ligand. We therefore analyzed Foxp3 expression by flow cytometry at different time points during the DC–T-cell coculture in the presence or absence of TLR7 ligand. We observed that the initial induction of Foxp3 expression by TGF-β within the first 2–3 days was not affected by addition of TLR7 ligand (Fig. 4A, left panel). Foxp3 is functional at this

early time point, since Foxp3+ T cells isolated from TLR7 ligand containing PLEK2 cocultures at day 2 suppress responder T-cell proliferation as efficiently as Foxp3+ T cells generated in the absence of TLR7 ligand (Fig. 5A, left panel). However, the percentage of Foxp3+ cells decreased progressively after 3 days in cocultures treated with TLR7 ligand, whereas it remained relatively stable in the absence of TLR7 ligand. In addition, the mean fluorescence intensity (MFI) of Foxp3 staining in Foxp3+ cells was significantly reduced in Tregs generated in the presence of TLR7 ligand in comparison to Tregs generated in the absence of TLR7 ligand at days 4 and 5 but not at earlier time points (Fig. 4A, right panel). IL-6 is already produced early after the beginning of the coculture stimulated with TLR7 ligand (day 1) and then further increases with incubation time (Supporting Information Fig. S2A).